Dew, Any opinion on Sepracor? I was tempted to short them a month or so ago when the Xopenex Medicare reimbursement news hit, but chickened out. Looks like Lunesta is also running into a lot of competition. Just curious at what level you'd start considering Sepracor an attractive value play?
Market cap is now down to only $3 bil, with over $500 mil in cash (though over $700 mil in debt). Revenues had been well over a Bil/yr, but are rapidly being adjusted downward. Thanks for any input.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.